AU2001238596A1 - 18607, a novel human calcium channel - Google Patents

18607, a novel human calcium channel

Info

Publication number
AU2001238596A1
AU2001238596A1 AU2001238596A AU3859601A AU2001238596A1 AU 2001238596 A1 AU2001238596 A1 AU 2001238596A1 AU 2001238596 A AU2001238596 A AU 2001238596A AU 3859601 A AU3859601 A AU 3859601A AU 2001238596 A1 AU2001238596 A1 AU 2001238596A1
Authority
AU
Australia
Prior art keywords
calcium channel
novel human
human calcium
novel
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001238596A
Inventor
Rory A. J. Curtis
Maria Alexandra Glucksmann
Jose M. Lora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001238596A1 publication Critical patent/AU2001238596A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001238596A 2000-02-22 2001-02-20 18607, a novel human calcium channel Abandoned AU2001238596A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US51070600A 2000-02-22 2000-02-22
US09510706 2000-02-22
US58337300A 2000-05-31 2000-05-31
US09583373 2000-05-31
US63466900A 2000-08-08 2000-08-08
US09634669 2000-08-08
PCT/US2001/005529 WO2001062794A2 (en) 2000-02-22 2001-02-20 18607, a human calcium channel

Publications (1)

Publication Number Publication Date
AU2001238596A1 true AU2001238596A1 (en) 2001-09-03

Family

ID=27414465

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001238596A Abandoned AU2001238596A1 (en) 2000-02-22 2001-02-20 18607, a novel human calcium channel

Country Status (3)

Country Link
US (1) US20020142377A1 (en)
AU (1) AU2001238596A1 (en)
WO (1) WO2001062794A2 (en)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417671A1 (en) 2000-07-28 2002-02-07 Ulrich Wissenbach Trp8, trp9 and trp10, novel markers for cancer
EP1423538A4 (en) * 2001-09-17 2005-06-29 Millennium Pharm Inc Methods of using 5433, a human calcium channel family member
US7452675B2 (en) * 2002-01-25 2008-11-18 The Queen's Medical Center Methods of screening for TRPM4b modulators
AU2003226797A1 (en) * 2002-04-16 2003-10-27 Bayer Healthcare Ag Regulation of human transient receptor potential channel
AU2003259913A1 (en) * 2002-08-19 2004-03-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
BR122018071808B8 (en) 2003-11-06 2020-06-30 Seattle Genetics Inc conjugate
KR101200133B1 (en) 2004-06-01 2012-11-13 제넨테크, 인크. Antibody drug conjugates and methods
CA2580141C (en) 2004-09-23 2013-12-10 Genentech, Inc. Cysteine engineered antibodies and conjugates
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
JP5188498B2 (en) * 2006-05-25 2013-04-24 ザ・クイーンズ・メディカル・センター Methods for screening for TRPM4 modulators of insulin secretion
US8638228B2 (en) 2007-02-02 2014-01-28 Hartford Fire Insurance Company Systems and methods for sensor-enhanced recovery evaluation
IN2012DN03025A (en) 2009-09-09 2015-07-31 Ct Se Llc
BR112012026213B1 (en) 2010-04-15 2021-12-28 Medimmune Limited PYRROLOBENZODIAZEPINE COMPOUNDS, CONJUGATE THEREOF, PHARMACEUTICAL COMPOSITION INCLUDING CONJUGATE AND USE THEREOF FOR TREATMENT OF A PROLIFERATIVE DISEASE
CA2799540A1 (en) 2010-06-08 2011-12-15 Genentech, Inc. Cysteine engineered antibodies and conjugates
JP5889912B2 (en) 2010-11-17 2016-03-22 ジェネンテック， インコーポレイテッド Alaninyl maytansinol antibody conjugate
CA2833212C (en) 2011-05-12 2020-06-09 Genentech, Inc. Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides
KR101877598B1 (en) 2011-10-14 2018-07-11 메디뮨 리미티드 Pyrrolobenzodiazepines and conjugates thereof
WO2013130093A1 (en) 2012-03-02 2013-09-06 Genentech, Inc. Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
ES2660029T3 (en) 2012-10-12 2018-03-20 Medimmune Limited Antibody-pyrrolobenzodiazepine conjugates
ES2703151T3 (en) 2012-10-12 2019-03-07 Adc Therapeutics Sa Pyrrolobenzodiazepine antibody conjugates
SI2906296T1 (en) 2012-10-12 2018-06-29 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
HUE035694T2 (en) 2012-10-12 2018-05-28 Adc Therapeutics Sa Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
EP2906250B1 (en) 2012-10-12 2018-05-30 ADC Therapeutics SA Pyrrolobenzodiazepine-anti-psma antibody conjugates
PT2839860T (en) 2012-10-12 2019-07-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
NZ707486A (en) 2012-10-12 2018-09-28 Adc Therapeutics Sa Pyrrolobenzodiazepine - anti-psma antibody conjugates
EA031585B1 (en) 2012-12-21 2019-01-31 Медимьюн Лимитед Pyrrolobenzodiazepines and conjugates thereof
CN105246894A (en) 2012-12-21 2016-01-13 斯皮罗根有限公司 Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
JP6444902B2 (en) 2013-03-13 2018-12-26 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ Pyrrolobenzodiazepine and its conjugates
CN105142674B (en) 2013-03-13 2018-11-13 麦迪穆有限责任公司 Pyrrolobenzodiazepines Zhuo and its conjugate
NZ710745A (en) 2013-03-13 2019-03-29 Genentech Inc Pyrrolobenzodiazepines and conjugates thereof
AU2014307080B2 (en) 2013-08-12 2018-06-07 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1H-benzo(E)indole dimer antibody-drug conjugate compounds, and methods of use and treatment
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
EP3054985B1 (en) 2013-10-11 2018-12-26 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
EP3054983B1 (en) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
JP6895254B2 (en) 2013-12-16 2021-06-30 ジェネンテック， インコーポレイテッド Peptidomimetic compounds and their antibodies-drug conjugates
CA2928952A1 (en) 2013-12-16 2015-06-25 Genentech, Inc. Peptidomimetic compounds and antibody-drug conjugates thereof
CA2929565A1 (en) 2013-12-16 2015-06-25 Genentech, Inc. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
US10188746B2 (en) 2014-09-10 2019-01-29 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
US10077318B2 (en) 2014-09-12 2018-09-18 Genentech, Inc. Cysteine engineered antibodies and conjugates
EP3191134B1 (en) 2014-09-12 2019-11-20 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
MA40575A (en) 2014-09-17 2016-03-24 Genentech Inc Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
AU2015352545B2 (en) 2014-11-25 2020-10-15 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
WO2016090050A1 (en) 2014-12-03 2016-06-09 Genentech, Inc. Quaternary amine compounds and antibody-drug conjugates thereof
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
MA43345A (en) 2015-10-02 2018-08-08 Hoffmann La Roche PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
MA43354A (en) 2015-10-16 2018-08-22 Genentech Inc CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE
MA45326A (en) 2015-10-20 2018-08-29 Genentech Inc CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
JP6943872B2 (en) 2016-03-25 2021-10-06 ジェネンテック， インコーポレイテッド Multiple whole antibody and antibody complex drug quantification assay
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
JP2019522633A (en) 2016-05-20 2019-08-15 ジェネンテック， インコーポレイテッド PROTAC antibody conjugates and methods of use
US20170370906A1 (en) 2016-05-27 2017-12-28 Genentech, Inc. Bioanalytical analysis of site-specific antibody drug conjugates
EP3464280B1 (en) 2016-06-06 2021-10-06 F. Hoffmann-La Roche AG Silvestrol antibody-drug conjugates and methods of use
EP3496763A1 (en) 2016-08-11 2019-06-19 Genentech, Inc. Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
EP3522933B1 (en) 2016-10-05 2021-12-15 F. Hoffmann-La Roche AG Methods for preparing antibody drug conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
RS61795B1 (en) 2017-02-08 2021-06-30 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
WO2018192944A1 (en) 2017-04-18 2018-10-25 Medimmune Limited Pyrrolobenzodiazepine conjugates
EP3612234B1 (en) 2017-04-20 2024-03-13 ADC Therapeutics SA Combination therapy with an anti-axl antibody-drug conjugate
MX2019015042A (en) 2017-06-14 2020-08-06 Adc Therapeutics Sa Dosage regimes for the administration of an anti-cd19 adc.
AU2018316532B2 (en) 2017-08-18 2022-11-24 Medimmune Limited Pyrrolobenzodiazepine conjugates
IL273387B2 (en) 2017-09-20 2023-10-01 Ph Pharma Co Ltd Thailanstatin analogs
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
GB201814281D0 (en) 2018-09-03 2018-10-17 Femtogenix Ltd Cytotoxic agents
JP2022505450A (en) 2018-10-24 2022-01-14 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト Conjugated chemical decomposition inducers and usage
WO2020123275A1 (en) 2018-12-10 2020-06-18 Genentech, Inc. Photocrosslinking peptides for site specific conjugation to fc-containing proteins
GB201901197D0 (en) 2019-01-29 2019-03-20 Femtogenix Ltd G-A Crosslinking cytotoxic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919638A (en) * 1996-10-08 1999-07-06 Abbott Laboratories Reagents and methods useful for detecting prostate tumors
PL196260B1 (en) * 1997-02-25 2007-12-31 Corixa Corp Polypeptide, dna molecule, host cell, fusion protein, pharmaceutical compositions and vaccines for the treatment of prostate cancer
ATE407949T1 (en) * 1998-12-30 2008-09-15 Beth Israel Hospital CHARACTERIZATION OF THE PROTEIN FAMILY OF SOC/CRAC CALCIUM CHANNELS

Also Published As

Publication number Publication date
WO2001062794A2 (en) 2001-08-30
WO2001062794A3 (en) 2002-05-02
US20020142377A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
AU2001238596A1 (en) 18607, a novel human calcium channel
AU2002224480A1 (en) Lace-less shoe
AU2001261572A1 (en) 38594, a novel human transporter and uses thereof
AU2001271455A1 (en) A human calcium channel protein and uses thereof
AU2002227925A1 (en) Human beta-defensin-3
AU1782201A (en) 2786, a novel human aminopeptidase
AU2002338572A1 (en) 66784, a novel human potassium channel and uses therefor
AU2001241728A1 (en) 25312, a novel human agmatinase-like homolog
AU2001266728A1 (en) 56201, a novel human sodium ion channel family member and uses thereof
AU2001268440A1 (en) 53320, a human acyltransferase and uses therefor
AU2001238707A1 (en) 32705, 23224, 27423, 32700, 32712, novel human g-proteins
AU2001284590A1 (en) Shoe
AUPR069500A0 (en) Tissue modification
AU2001268435A1 (en) 23680, a novel human aminotransferase and uses therefor
AU6204300A (en) 22012, a novel human carboxypeptidase
AU2001294724A1 (en) 56115, a novel human twik potassium channel and uses therefor
AU2001239965A1 (en) 23927, a novel human ion channel
AU2001275338A1 (en) 21784, a novel human calcium channel family member and uses thereof
AU2001294723A1 (en) 25658, a novel human calcium channel subunit and uses thereof
AU2002211512A1 (en) 25219, a novel human aminotransferase and uses therefor
AU2002211492A1 (en) 57800, a novel human cadherin and uses therefor
AU2001296307A1 (en) 55054, a human metalloprotease and uses therefor
AU2001291135A1 (en) 63760, a novel human transporter and uses thereof
AU2001249697A1 (en) 32449, a novel human transporter and uses thereof
AU2001253908A1 (en) 47615, a novel human ion channel and uses thereof